ZHEJIANG SHAPUAISI PHARMACEUTICAL financial statements, including revenue, expenses, profit, and loss

The total revenue of 603168 for the last quarter is 142.83 M CNY, and it's 8.30% lower compared to the previous quarter. The net income of Q4 23 is -54.04 M CNY.